Bausch+Lomb Results Presentation Deck

Segment Reported Revenue Vision Care Contact Lens Revenue Consumer Revenue Total Revenue Surgical Implantables Revenue Equipment Revenue Consumables Revenue Total Revenue Ophthalmic Pharmaceuticals Total Revenue BAUSCH + LOMB 4Q22 $219M $407M $626M 4Q22 $51M $37M $100M $188M 4Q22 $182M 4Q21 $227M $399M $626M 4Q21 $50M $43M $105M $198M 4Q21 $177M Reported Change (4%) 2% 0% Reported Change 2% (14%) (5%) (5%) Reported Change 3% 1. This is a non-GAAP measure or ratio. See Slide 2 and this Appendix for further information on non-GAAP measures and ratios. 2. Organic revenue growth/change, a non-GAAP ratio, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of acquisitions, divestitures and discontinuations. Organic Change %¹,2 4% 6% 5% Organic Change % ¹,2 13% (5%) 3% 4% Organic Change %¹,2 7% 33

View entire presentation